drugset / Trial / NCT00960830
Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and Anxiety
RandomizedFactorialDouble-blindPrevention
Summary
The purpose of this study is to evaluate if the use of antidepressant medication in depressed patients with implantable cardioverter defibrillator reduces the number of ICD's shocks as it improves depressive affect.
Timeline
- Start
- 2007-04
- Primary completion
- 2008-04
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mirtazapine | Other / unclassified | 15 mg | — |